Skip to main content

Table 4 Pathologic complete response and radiologic response rate according to ER/PR/c-erbB2

From: Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer

   No. of Pts pCR (N = 11) p-value Radiologic Response (RR %) p-value
Variables    No. of Pts (%)   No. of Pts (%)  
ER Positive 64 1 (1.6) 0.023 41 (64.1) 0.257
  Negative 81 10 (12.3)   59 (72.8)  
PR Positive 44 1 (2.3) 0.173 28 (63.6) 0.360
  Negative 101 10 (9.9)   72 (71.3)  
c-erbB2 0/+/++ 107 9 (8.4) 0.728 76 (71.0) 0.368
  +++ 38 2 (5.3)   24 (63.2)